Suppression of NANOG Expression Reduces Drug Resistance of Cancer Stem Cells in Glioblastoma

Glioblastoma (GBM) is an aggressive and incurable primary brain tumor that harbors therapy-resistant cancer stem cells (CSCs). Due to the limited effectiveness of conventional chemotherapies and radiation treatments against CSCs, there is a critical need for the development of innovative therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jonhoi, Field, Melvin, Sugaya, Kiminobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297980/
https://www.ncbi.nlm.nih.gov/pubmed/37372456
http://dx.doi.org/10.3390/genes14061276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297980/
https://www.ncbi.nlm.nih.gov/pubmed/37372456
http://dx.doi.org/10.3390/genes14061276

Ejemplares similares